ERBB2 and breast cancer: A meta-analysis reported significantly higher levels of cargo molecules human epidermal growth factor receptor 2 (HER2), CD47, Del-1, miR-1246, and miR-21) in small EVs (sEVs) from breast cancer patients compared to healthy controls and those with benign breast tumors [46].